SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-23-001412
Filing Date
2023-08-08
Accepted
2023-08-08 16:30:53
Documents
43
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q e4887_10-q.htm   iXBRL 10-Q 771559
2 EXHIBIT 31.1 e4887_ex31-1.htm EX-31.1 8800
3 EXHIBIT 31.2 e4887_ex31-2.htm EX-31.2 8783
4 EXHIBIT 32.1 e4887_ex32-1.htm EX-32.1 6835
5 GRAPHIC image_001.jpg GRAPHIC 42091
6 GRAPHIC image_002.jpg GRAPHIC 28316
  Complete submission text file 0001731122-23-001412.txt   3335449

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE avxl-20230630.xsd EX-101.SCH 27321
8 XBRL CALCULATION FILE avxl-20230630_cal.xml EX-101.CAL 26958
9 XBRL DEFINITION FILE avxl-20230630_def.xml EX-101.DEF 85197
10 XBRL LABEL FILE avxl-20230630_lab.xml EX-101.LAB 202286
11 XBRL PRESENTATION FILE avxl-20230630_pre.xml EX-101.PRE 156127
37 EXTRACTED XBRL INSTANCE DOCUMENT e4887_10-q_htm.xml XML 422586
Mailing Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111
Business Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111 844-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37606 | Film No.: 231151919
SIC: 2836 Biological Products, (No Diagnostic Substances)